Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density.
Belfrage, Ola LU ; Flivik, Gunnar LU ; Sundberg, Martin LU
; Kesteris, Uldis
LU
and Tägil, Magnus
LU
(2011)
In Acta Orthopaedica
82(2).
p.228-233
- Abstract
- Background and purpose The remodeling of morselized bone grafts in revision surgery can be enhanced by an anabolic substance such as a bone morphogenetic protein (BMP). On the other hand, BMPs boost catabolism and might cause a premature resorption, both of the graft and of the new-formed bone. Bisphosphonates inactivate osteoclasts and can be used to control the resorption. We studied a combination of both drugs as a local admix to a cancellous allograft. Methods Cancellous bone allografts were harvested and freeze-dried. Either saline, BMP-7, the bisphosphonate zoledronate, or a combination of BMP-7 and zoledronate were added in solution. The grafts were placed in bone conduction chambers and implanted in the proximal tibia of 34 rats.... (More)
- Background and purpose The remodeling of morselized bone grafts in revision surgery can be enhanced by an anabolic substance such as a bone morphogenetic protein (BMP). On the other hand, BMPs boost catabolism and might cause a premature resorption, both of the graft and of the new-formed bone. Bisphosphonates inactivate osteoclasts and can be used to control the resorption. We studied a combination of both drugs as a local admix to a cancellous allograft. Methods Cancellous bone allografts were harvested and freeze-dried. Either saline, BMP-7, the bisphosphonate zoledronate, or a combination of BMP-7 and zoledronate were added in solution. The grafts were placed in bone conduction chambers and implanted in the proximal tibia of 34 rats. The grafts were harvested after 6 weeks and evaluated by histomorphometry. Results Bone volume/total volume (BV/TV) was 50% in the grafts treated with the combination of BMP-7 and zoledronate and 16% in the saline controls (p < 0.001). In the zoledronate group BV/TV was 56%, and in the BMP group it was 14%. The ingrowth distance of new bone into the graft was 3.5 mm for the combination of BMP-7 and zoledronate and 2.6 mm in the saline control (p = 0.002). The net amount of retained remodeled bone was more than 4 times higher when BMP-7 and zoledronate were combined than in the controls. Interpretation An anabolic drug like BMP-7 can be combined with an anti-catabolic bisphosphonate as local bone graft adjunct, and the combination increases the amount of remaining bone after remodeling is complete. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1883498
- author
- Belfrage, Ola
LU
; Flivik, Gunnar
LU
; Sundberg, Martin
LU
; Kesteris, Uldis
LU
and Tägil, Magnus
LU
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Acta Orthopaedica
- volume
- 82
- issue
- 2
- pages
- 228 - 233
- publisher
- Taylor & Francis
- external identifiers
-
- wos:000289170900018
- pmid:21434769
- scopus:79953814937
- pmid:21434769
- ISSN
- 1745-3682
- DOI
- 10.3109/17453674.2011.566138
- language
- English
- LU publication?
- yes
- id
- 947bfd90-2a14-41cd-911c-e4c0cea29a59 (old id 1883498)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/21434769?dopt=Abstract
- date added to LUP
- 2016-04-01 13:03:41
- date last changed
- 2022-01-27 17:06:30
@article{947bfd90-2a14-41cd-911c-e4c0cea29a59,
abstract = {{Background and purpose The remodeling of morselized bone grafts in revision surgery can be enhanced by an anabolic substance such as a bone morphogenetic protein (BMP). On the other hand, BMPs boost catabolism and might cause a premature resorption, both of the graft and of the new-formed bone. Bisphosphonates inactivate osteoclasts and can be used to control the resorption. We studied a combination of both drugs as a local admix to a cancellous allograft. Methods Cancellous bone allografts were harvested and freeze-dried. Either saline, BMP-7, the bisphosphonate zoledronate, or a combination of BMP-7 and zoledronate were added in solution. The grafts were placed in bone conduction chambers and implanted in the proximal tibia of 34 rats. The grafts were harvested after 6 weeks and evaluated by histomorphometry. Results Bone volume/total volume (BV/TV) was 50% in the grafts treated with the combination of BMP-7 and zoledronate and 16% in the saline controls (p < 0.001). In the zoledronate group BV/TV was 56%, and in the BMP group it was 14%. The ingrowth distance of new bone into the graft was 3.5 mm for the combination of BMP-7 and zoledronate and 2.6 mm in the saline control (p = 0.002). The net amount of retained remodeled bone was more than 4 times higher when BMP-7 and zoledronate were combined than in the controls. Interpretation An anabolic drug like BMP-7 can be combined with an anti-catabolic bisphosphonate as local bone graft adjunct, and the combination increases the amount of remaining bone after remodeling is complete.}},
author = {{Belfrage, Ola and Flivik, Gunnar and Sundberg, Martin and Kesteris, Uldis and Tägil, Magnus}},
issn = {{1745-3682}},
language = {{eng}},
number = {{2}},
pages = {{228--233}},
publisher = {{Taylor & Francis}},
series = {{Acta Orthopaedica}},
title = {{Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density.}},
url = {{http://dx.doi.org/10.3109/17453674.2011.566138}},
doi = {{10.3109/17453674.2011.566138}},
volume = {{82}},
year = {{2011}},
}